Participants 39 71 3
patients with serious infections
Participants 240 402 4
consecutive patients with serious infections for whom an aminoglycoside seemed warranted. Exclusion criteria were neutropenia or severely impaired renal function.
Participants 403 430 5
123 patients were enrolled.
Participants 431 700 5
For efficacy analysis only those patients were considered in whom treatment with the aminoglycoside was not stopped within 72 h (n = 67); toxicity was analysed on patients receiving aminoglycosides for more than 48 h and not using other nephrotoxic medication (n = 85).
